Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 14:10.1002/art.43185.
doi: 10.1002/art.43185. Online ahead of print.

Time-Dependent Effect of Prophylactic Trimethoprim-Sulfamethoxazole on the Incidence of Serious Infections in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Target Trial Emulation Study

Yun Kyu Kim  1 , Jeffrey R Curtis  2 , Se Rim Choi  3 , Jina Yeo  4 , Min Jung Kim  5 , Yun Jong Lee  6 , Eun Bong Lee  7 , Jun Won Park  1
Affiliations

Time-Dependent Effect of Prophylactic Trimethoprim-Sulfamethoxazole on the Incidence of Serious Infections in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Target Trial Emulation Study

Yun Kyu Kim et al. Arthritis Rheumatol. .

Abstract

Objective: The objective of this study was to investigate the effect of prophylactic trimethoprim-sulfamethoxazole (TMP-SMX) on the incidence of serious infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV).

Methods: This multicenter cohort study was designed to emulate a target trial that studied 296 patients with AAV who were treated with rituximab (RTX) or cyclophosphamide (CYC) as induction therapy. Patients were grouped based on the administration of TMP-SMX within 14 days following induction therapy (n = 240 and 56 patients in prophylaxis and control groups, respectively) (intention-to-treat) and also as a time-dependent exposure (time-varying). Inverse probability weighting was applied to minimize the baseline imbalance between the two groups. The primary outcome was one-year incidence of serious infection.

Results: During the 252.1 person-years of observation, 77 cases of serious infections were recorded in 65 patients with a fatality rate of 18.5%. Most serious infections (n = 66, 85.7%) occurred within the first 180 days of observation. The prophylaxis group showed a significantly lower incidence of serious infections than the control group (hazard ratio [HR] 0.48 [95% confidence interval (CI) 0.32-0.72]). However, this beneficial effect of TMP-SMX was only significant during the first 180 days (HR 0.41 [95% CI 0.22-0.76]) and not thereafter (HR 3.67 [95% CI 0.46-29.43]) (interaction P = 0.044). This result was also consistent with the time-varying analysis result. Based on one case of severe adverse drug reaction related to TMP-SMX, the number needed to harm was 127.4, whereas the number needed to treat to prevent one serious infection was 8.0.

Conclusion: Prophylactic TMP-SMX significantly reduced the risk of serious infections in patients with AAV, particularly during the first six months of induction therapy with RTX or CYC.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65:1–11. - PubMed
    1. Sanchez Alamo B, Moi L, Bajema I, et al. Long-term outcomes and prognostic factors for survival of patients with anca-associated vasculitis. Nephrol Dial Transplant 2023; 38:1655–1665. - PubMed
    1. Robson J, Doll H, Suppiah R, et al. Damage in the anca-associated vasculitides: Long-term data from the european vasculitis study group (euvas) therapeutic trials. Ann Rheum Dis 2015; 74:177–184. - PubMed
    1. Yates M, Watts RA, Bajema IM, et al. Eular/era-edta recommendations for the management of anca-associated vasculitis. Ann Rheum Dis 2016; 75:1583–1594. - PubMed
    1. Kronbichler A, Jayne DR, Mayer G. Frequency, risk factors and prophylaxis of infection in anca-associated vasculitis. Eur J Clin Invest 2015; 45:346–368. - PubMed

LinkOut - more resources